Investigation of Deteriorating Kidney Transplant Function Investigation of Deteriorating Kidney Transplant Function
This author discusses the important role of kidney biopsies in the diagnosis and work-up of deteriorating transplants.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2022 Category: Consumer Health News Tags: Transplantation Journal Article Source Type: news

Many Kidney Transplant Recipients Back to Work
THURSDAY, Sept. 29, 2022 -- Employed kidney transplant recipients report that they function very well at work, according to a study published online Sept. 26 in the Clinical Journal of the American Society of Nephrology. Tim J. Knobbe, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 29, 2022 Category: Pharmaceuticals Source Type: news

Two Cases Show COVID Virus Mutating Around Standard Treatment Remdesivir
WEDNESDAY, Sept. 28, 2022 -- Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 28, 2022 Category: General Medicine Source Type: news

Post-Transplant Diabetes Can Be Predicted in Kidney Recipients Post-Transplant Diabetes Can Be Predicted in Kidney Recipients
Combined family history and early postoperative plasma glucose, but not glycated albumin, predicted post-transplant diabetes mellitus in kidney recipients in a new study.First Look (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - September 27, 2022 Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news

Race-Free Creatinine Equation May Cut Disparity in Kidney Wait Time
TUESDAY, Sept. 27, 2022 -- Use of the creatinine race-free 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation to determine eligibility for the kidney transplant wait list may reduce racial differences in preemptive wait time... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 27, 2022 Category: Pharmaceuticals Source Type: news

New NHS immune cell jab could reduce kidney transplant failures - as army veteran sees trial success
Chris Holmes (pictured), 31, a former Army paramedic who served in Afghanistan, is one of more than 150 patients worldwide taking part in the trial. He has had a kidney transplant. (Source: the Mail online | Health)
Source: the Mail online | Health - September 24, 2022 Category: Consumer Health News Source Type: news

Nixing'Race Adjustment' May Up Kidney Transplant Odds for Blacks Nixing'Race Adjustment' May Up Kidney Transplant Odds for Blacks
Creatinine-based eGFR is best at reducing racial differences in access to kidney transplants, show new data. But nixing race-based adjustment of eGFR may have other unintended consequences, say editorialists.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 23, 2022 Category: Intensive Care Tags: Nephrology News Source Type: news

Nixing'Race Adjustment' May Up Kidney Transplant Odds for Black Patients Nixing'Race Adjustment' May Up Kidney Transplant Odds for Black Patients
Creatinine-based eGFR is best at reducing racial differences in access to kidney transplants, show new data. But nixing race-based adjustment of eGFR may have other unintended consequences, say editorialists.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - September 23, 2022 Category: Pathology Tags: Nephrology News Source Type: news

Robotic kidney transplant done at Safdarjung Hospital, doctors claim first for a government facility
The patient, a native of Farrukhabad in Uttar Pradesh, had a kidney failure and was awaiting a transplant for the past five years, said Dr Anup Kumar, head of the department of Urology, Robotics and Renal Transplant, who performed the surgery. (Source: The Economic Times)
Source: The Economic Times - September 22, 2022 Category: Consumer Health News Source Type: news

Medical Education Has 'Gone Woke' -- That's a Good Thing
(MedPage Today) -- A Black woman whose kidneys only function at 15% of normal wishes to be evaluated for a kidney transplant. Although this is very reasonable, before 2021, many physicians would have said, "I'm sorry, but your kidney function is... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - September 7, 2022 Category: American Health Source Type: news

Outcomes of Living, Unrelated Donor Kidney Transplants in Children Examined
THURSDAY, Sept. 1, 2022 -- Graft survival is comparable for pediatric recipients of living unrelated donor (LURD) and living related donor (LRD) kidneys, according to a study published online July 23 in Pediatric Transplantation. Lavjay Butani,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 1, 2022 Category: Pharmaceuticals Source Type: news

Dropping Immunosuppression in COVID Didn't Up Transplant Rejection Dropping Immunosuppression in COVID Didn't Up Transplant Rejection
For kidney transplant recipients who have COVID-19, rates of acute rejection are low despite reducing their immunosuppressant regimens.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - September 1, 2022 Category: Internal Medicine Tags: Nephrology News Source Type: news

Autistic kidney-row teen's transplant 'a success'
The mother who went to court to secure her son a life-saving operation says he has "defied all odds". (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 30, 2022 Category: Consumer Health News Source Type: news

Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX ® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma
LOS ANGELES, August 27, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the randomized Phase 2 GRIFFIN study evaluating the investigational use of DARZALEX® (daratumumab) in combination with lenalidomide (Revlimid®), bortezomib (VELCADE®) and dexamethasone (DARZALEX®-RVd), followed by maintenance therapy with DARZALEX®-lenalidomide (R), compared to RVd followed by maintenance therapy with R alone, in patients with newly diagnosed, transplant-eligible multiple myeloma. Data were presented in the plenary session at the 19th International Myeloma Society (IMS)...
Source: Johnson and Johnson - August 28, 2022 Category: Pharmaceuticals Source Type: news

HCV-Positive Kidney Allograft Survival Just as Good at 5 Years
(MedPage Today) -- Transplantation of kidneys positive for hepatitis C virus (HCV) resulted in outcomes that were statistically no different than with uninfected kidney transplants, a retrospective U.S.-based cohort study indicated. No significant... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 26, 2022 Category: American Health Source Type: news